Intervet Inc.

Intervet International B.v.

Akzo Nobel N.v.

Other

Internet International B.u.

Antonius Arnoldus Christiaan Jacobs

Paul Vermeij

Carla Christina Schrier

Ruud Philip Antoon Maria Segers

Melanie Sno

Petrus Johannes Maria Nuijten

Maarten Hendrik Witvliet

Johannes Franciscus Van Den Bosch

Mohamad A Morsey

Vicky Fachinger

Lubbert Dijkhuizen

Robert Van Der Geize

Yugang Luo

Erwin Van Den Born

Yvonne Maria Johanna Corina Biermann

Erwin Born Van Den

Theodora Johanna Van Kasteren-Westerneng

Daniel G E Goovaerts

Paul Cornelius Maria Van Empel

Christa Drexler

Theodora Johanna Van Kasteren - Westerneng

The present invention pertains to a vaccine comprising in combination an IgM protease antigen ofand abacterin of serotype (9), sequence type (16), for use in a method for protecting pigs against a pathogenic infection withserotype (9), sequence type (16).

Vaccine for protection againstserotype 9, sequence type 16

The present invention pertains to a vaccine comprising an immunologically effective amount of an IgM protease antigen of, for use in a method for protecting pigs against a pathogenic infection withby administering the vaccine only once, wherein the vaccine comprises at most 120 μg per dose of the antigen.

Vaccine for protection against

The present invention pertains to a vaccine comprising an IgM protease antigen of, for use in a method for protecting a pig against, characterised in that the IgM protease antigen is a protein according to SEQ ID NO:1.

The present invention pertains to a vaccine comprising an IgM protease antigen of, for use in a method for protecting pigs against an infection withof serotype 2 and against an infection withof serotype 14.

The present invention pertains to a vaccine comprising (a) an immunologically effective amount of aIgM protease antigen, (b) an immunologically effective amount of anfibmrial antigen, and (c) an immunologically effective amount of atoxoid, and also pertains to use of the vaccine in a method for protecting pigs against a pathogenic infection withand

Combination vaccine

The present invention pertains to a combination of a first vaccine comprising non-replicating immunogen of porcine circo virus type 2 (PCV2) and non-replicating immunogen of, and a second vaccine comprising live attenuated porcine reproductive and respiratory syndrome (PRRS) virus, for use in prophylactically treating an animal against an infection with porcine circovirus type 2, an infection withand an infection with PRRS virus, by associated non-mixed administration of the first vaccine and the second vaccine to the animal. The invention also pertains to a kit-of-parts comprising the first and second vaccine and to a method of protecting an animal against such infections using these vaccines.

Vaccines containing swine pathogens for associated non-mixed use

The present invention pertains to a vaccine comprising an IgM protease antigen of, for use in a method for protecting piglets having maternally derived anti-antibodies against, by administering the vaccine to the piglets at an age of at most 28 days, preferably before the piglets are weaned.

The invention pertains to a vaccine comprising in combination non-replicating immunogens of, porcine parvo virus,and live attenuated PRRS virus, and a pharmaceutically acceptable carrier, for use in a method for prophylactic treatment of a swine against an infection with, porcine parvo virus,and PRRS virus, wherein the vaccine is administered in a single dose with regard to the treatment against an infection with PRRS virus.

Swine vaccine

The present invention pertains to a vaccine comprising an IgM protease antigen of, for use in a method for protecting pigs against an infection withof serotype 2 and against an infection withof serotype 9.

The present invention pertains to a vaccine comprising an IgM protease antigen of, for use in a method wherein a female pig is vaccinated in order to protect a piglet againstthrough the intake of colostrum of the vaccinated female pig.

The present invention pertains to a vaccine comprising non liveantigen and a pharmaceutically acceptable carrier for use in a method to reduce in a pig the negative impact on average daily weight gain (ADWG) associated with subclinical infection with, by systemic administration of the vaccine to the pig.

Vaccine for use against subclinicalinfection in a pig

The present invention pertains to a vaccine comprising non liveantigen and a pharmaceutically acceptable carrier for use in a method to reduce in a pig the shedding ofbacteria associated with subclinical infection with, by systemic administration of the vaccine to the pig.

[object Object]

The present invention pertains to a vaccine comprising in combination killed whole cell Lawsonia intracellularis bacteria and porcine circo virus 2 (PCV2) ORF2 protein for use in protecting a pig against an infection with Lawsonia intracellularis and PCV2 by an intradermal administration of the vaccine. The invention also pertains to a method to protect a swine against an infection with Lawsonia intracellularis bacteria and PCV2.

Vaccine against Lawsonia intracellularis and porcine circovirus 2

The present invention pertains to a vaccine comprising live attenuatedbacteria for protection of a ruminant against pneumonia caused byby administration of the vaccine to the upper respiratory tract of the ruminant via intranasal atomization of the vaccine. The invention also pertains to a method to use the vaccine to protect a ruminant against pneumonia caused bybacteria.

Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida

The present invention pertains to a vaccine for administration to the upper respiratory tract of a ruminant to protect said ruminant against pneumonia caused by, the vaccine comprising in combination live attenuatedbacteria, live attenuated parainfluenza-3 virus and live attenuated bovine respiratory syncytial virus, wherein the vaccine is for administration to the upper respiratory tract of the ruminant via intranasal atomization of the vaccine.

Growing community of inventors

Kessel, Netherlands

Antonius Arnoldus Christiaan Jacobs